H. pylori eradication linked to reduced risk of gastric cancer
Gastric cancer incidence and death half as likely over 22 years after short-term H. pylori treatment Related items fromOnMedica Antivirals cut liver cancer risk after hepatitis C Statins might not cut colorectal cancer risk after all Antibiotics, H2RAs and PPIs linked to child obesity Long-term use of PPIs linked to doubling in stomach cancer risk Taking aspirin with a PPI reduces risk of oesophageal cancer
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Aspirin | Cancer | Cancer & Oncology | Children | Cholesterol | Colorectal Cancer | Eating Disorders & Weight Management | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Helicobacter Pylori | Hepatitis | Hepatitis C | Liver | Obesity | Proton Pump Inhibitors PPIs | Statin Therapy | UK Health | Urology & Nephrology